Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack

Daniel H. Steinberg, Stefan C. Bertog, Julia Momberger, Jennifer Franke, Ilona Hofmann, Kristina Renkhoff, Sonya Joy, Laura Vaskelyte, Horst Sievert

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background Patent foramen ovale (PFO) is associated with cryptogenic strokes and transient ischemic attacks (TIAs). This study examined the initial experience with a new PFO occluder, the Nit-Occlud® PFO Occlusion Device. Methods Sixty-three patients with history of cryptogenic stroke or TIA and PFO underwent percutaneous closure of the defect with the Nit-Occlud® PFO Occlusion Device. The primary endpoint was successful implantation without recurrent event, device malfunction, embolization, or the need for a replacement device over 6±2 weeks. All patients underwent transesophageal echocardiography (TEE) at 6-weeks, and 42 patients had repeat TEE at 6-months. Clinical follow-up at 18.7±7.4 months was also performed. Results The device was successfully implanted in 62 (98.4%) patients with no relevant procedural complications. At 6-week follow-up, 60 (95.2%) patients met the primary endpoint. A residual shunt at rest and with Valsalva was noted in 8 (12.7%) and 31 (49.2%) patients respectively at 6-week TEE. At 6-months, 1 of 42 (2.4%) and 9 of 42 (21.4%) patients had a residual shunt at rest and with Valsava, respectively. At 18 months, 5/63 patients had recurrent events (3 TIAs, 2 strokes). No device-related complications occurred. One patient developed atrial fibrillation. Conclusion In patients with cryptogenic stroke or TIA and a PFO, the Nit-Occlud® PFO Occlusion Device appears to be both a safe and effective means to occlude the PFO. It is associated with high procedural success and favorable rates of complete closure.

Original languageEnglish (US)
Pages (from-to)1262-1267
Number of pages6
JournalCatheterization and Cardiovascular Interventions
Volume85
Issue number7
DOIs
StatePublished - Jun 1 2015

Keywords

  • ASD/PDA/PFO
  • closure
  • interventional devices/innovation
  • structural heart disease intervention

Fingerprint Dive into the research topics of 'Initial experience with the novel patent foramen ovale occlusion device Nit-Occlud® in patients with stroke or transient ischemic attack'. Together they form a unique fingerprint.

Cite this